Aspectos epidemiológicos da ocorrência do Enterococcus resistente a Vancomicina

Abstract

This descriptive study was conducted in a public hospital from May 2005 to October 2007, with the purpose to determine the epidemiological aspects that involve vancomycin-resistant enterococci (VRE) and describe the evolution of patients. |The data was obtained from registers on patient records and then processed in SPSS. Frequency distribution and measures of central tendency were used. A total 122 patients participated of the study, the majority were males with an average age of 43 years (SD= 18.8), and 16.3% developed VRE infection. Vancomycin has been the most used antibiotic (62,3%), 97.5% used invasive procedures, 45.0% were dependent on intensive care nursing, 77.9% had at least one open wound and 50.8% progressed to death. The data suggests that recommendations for bacterial resistance control should be encouraged to reduce mortality, morbidity, hospital costs and thus provide better quality care to patients. KEY WORDS RESUMENEstudio descriptivo, realizado en un hospital público desde mayo de 2005 a octubre de 2007. Se objetivó determinar los aspectos epidemiológicos que involucran al Enterococcus resistente a vancomicina (VRE) y describir la evolución de los pacientes. Los datos fueron recolectados de registros en historias clínicas, después de la recolección, la información obtenida fue procesada en SPSS. Se usó la distribución de frecuencia y medidas de tendencia central. Participaron del estudio 122 pacientes. La mayoría, de sexo masculino, con edad media de 43 años (DP = 18,8). El 16,3% desarrolló infección por VRE. El antibiótico más usado antes de la identificación del VRE fue la vancomicina. (62,3%); 93,5% fueron sometidos a procedimientos invasivos, 45,0% dependían de cuidado intensivo de enfermería, 77,9% tenía por lo menos una herida abierta y 50,8% fallecieron. Tales datos sugieren que deben ser alentadas en forma ilimitada medidas de control de la resistencia bacteriana, apuntando a la reducción de la mortalidad, morbilidad, costos hospitalarios y, consecuentemente, a una mejor calidad de atención del paciente. DESCRIPTORES

Molecular detection of <em>vanA</em> and <em>vanB</em> genes among vancomycin-resistant enterococci in ICU-hospitalized patients in Ahvaz in southwest of Iran

“…8 For example, the cost of treatment of infections caused by VRE is estimated ten times more than the treatment of enterococci without this resistance. 9 A multitude of studies have shown that patients with bacteremia caused by VRE have a higher mortality rate compared with patients with enterococci susceptible to these antibiotics. Patients infected or colonized with VRE are a source for spread of these bacteria, and the presence of VRE in the digestive system of patients is associated with clinically serious infections such as gastrointestinal tract infections.…”

Pré-operatório de cirurgias potencialmente contaminadas: fatores de risco para infecção do sítio cirúrgico

“…(27) However, in this study, SSI occurred in six (66.7%) independent participants, a fact corroborated by some studies. (21,(23)(24)(25)28) In the present study, five (55.6%) participants who needed ICU admission in the immediate postoperative period developed SSI. The fact of surgical patients admitted to ICU postoperatively developing SSI is justified by surgical stress due to the nature of the surgical procedure and clinical conditions.…”

Isolation and antimicrobial resistance profile for Enterococcus spp in goat milk processing plants

“…However, there is a discrepancy between findings reported by (Silvetti, et al, 2019, Frazzon, et al, 2010& Rivas, et al, 2012, who found no resistance to vancomycin in isolates from food, including milk. Vancomycin-resistant Enterococcus (VRE) are related with a significant increase in mortality, as well as a tenfold increase in hospital costs (Furtado, et al, 2005;Oliveira & Bettcher, 2010).…”